Quantigen

Quantigen is a specialty contract research organization (CRO) and CLIA-certified laboratory that provides advanced molecular diagnostic services and clinical trial support. The company specializes in the development, validation, and implementation of complex genomic assays, including PCR and next-generation sequencing (NGS) workflows. Quantigen serves a global clientele of pharmaceutical, biotech, and diagnostic companies, offering expertise in therapeutic areas such as infectious disease, oncology, and women's health. Following its acquisition by Discovery Life Sciences in 2024, Quantigen continues to operate as a specialized unit focused on high-throughput genomic testing and diagnostic innovation.